Market Valuation Validation and SupportRare Disease Markets
Our client needed a commercial consultation on how to best validate and support a fair valuation for a novel cardiovascular asset in phase 3.
Optio delivered the following:
- A market research plan optimized for greatest credibility with “big pharma” within a very limited budget.
- Crafted a backgrounder and product profile true to the accepted base case clinical trial outcome, but clear and compelling enough to capture the full commercial value of the asset.
- Referral to and collaboration with other research specialists and consultants capable of executing the entire market research plan.
Our client was able to execute the required market research and satisfactorily support their product valuation.